NASDAQ: AVAHAveanna Healthcare Holdings Inc Stock
$4.54-0.02 (-0.44%)
Updated Apr 17, 2025
AVAH Price
$4.54
Fair Value Price
N/A
Market Cap
$885.73M
52 Week Low
$2.15
52 Week High
$6.19
P/E
-75.67x
P/B
-7.17x
P/S
0.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.02B
Earnings
-$10.93M
Gross Margin
31.4%
Operating Margin
7.99%
Profit Margin
-0.5%
Debt to Equity
-14.45
Operating Cash Flow
$33M
Beta
1.25
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A
AVAH Overview
Aveanna Healthcare Holdings Inc. provides private duty nursing, adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the U.S. Its care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company was incorporated in 2016 and is headquartered in Atlanta, GA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AVAH's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
B
AVAH
Ranked#7 of 42
Ranked#7 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.82 | A | |
| $12.51 | A | |
| $174.80 | A |
Be the first to know about important AVAH news, forecast changes, insider trades & much more!
AVAH News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AVAH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AVAH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AVAH is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
AVAH's Earnings (EBIT) of $161.67M... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more AVAH due diligence checks available for Premium users.
Valuation
AVAH fair value
Fair Value of AVAH stock based on Discounted Cash Flow (DCF)
Price
$4.54
Fair Value
-$5.31
Undervalued by
185.43%
AVAH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AVAH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-75.67x
Industry
14.77x
Market
27.98x
AVAH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-7.17x
Industry
4.22x
AVAH's financial health
Profit margin
Revenue
$519.9M
Net Income
$29.2M
Profit Margin
5.6%
AVAH's Earnings (EBIT) of $161.67M... subscribe to Premium to read more.
Interest Coverage Financials
AVAH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7B
Liabilities
$1.8B
Debt to equity
-14.45
AVAH's short-term liabilities ($402.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AVAH's long-term liabilities ($1.38B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AVAH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AVAH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$13.4M
Investing
-$1.5M
Financing
-$6.1M
AVAH's operating cash flow ($32.64M)... subscribe to Premium to read more.
Debt Coverage Financials
AVAH vs Medical Care Facility Stocks
Aveanna Healthcare Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.